NHI director Tracy Colden (NYSE: NHI) awarded 1,268 restricted shares

Rhea-AI Filing Summary

COLDEN TRACY M J reported acquisition or exercise transactions in this Form 4 filing.

National Health Investors director receives stock grant. Director Tracy M. J. Colden was awarded 1,268 shares of National Health Investors common stock on March 3, 2026 as restricted stock. These shares vest in full on March 3, 2027, subject to continued board service, bringing her direct holdings to 12,858 shares.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

COLDEN TRACY M J

(Last) (First) (Middle)

222 ROBERT ROSE DR

(Street)

MURFREESBORO TN 37129

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
NATIONAL HEALTH INVESTORS INC [ NHI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
03/03/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/03/2026		A		1,268(1)	A	$0	12,858	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents a grant of restricted stock awarded on March 3, 2026, which vests in full on March 3, 2027, subject to the reporting person's continued service as a director through such date.

	/s/ Kimberly V. Ouimet, by limited power of attorney	03/04/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did NHI director Tracy Colden report on Form 4?

NHI director Tracy M. J. Colden reported receiving a grant of 1,268 shares of restricted common stock. The award was made on March 3, 2026 and increased her direct ownership to 12,858 shares after the transaction, according to the Form 4 filing details.

When do the restricted shares granted to NHI director Tracy Colden vest?

The 1,268 restricted shares granted to NHI director Tracy Colden vest in full on March 3, 2027. Vesting is conditioned on her continued service as a director through that date, meaning she must remain on the board for the award to fully vest.

How many NHI shares does Tracy Colden own after this Form 4 transaction?

After the reported award, NHI director Tracy Colden directly owns 12,858 shares of National Health Investors common stock. This total includes the newly granted 1,268 restricted shares, which are subject to vesting based on her continued service on the company’s board of directors.

Was the NHI director stock grant a market purchase or a compensation award?

The NHI director stock grant was a compensation award, not a market purchase. The Form 4 uses transaction code “A” for a grant, award, or other acquisition, and a footnote specifies it as restricted stock granted as part of her service as a director.

Does the NHI Form 4 indicate any shares were sold by director Tracy Colden?

The Form 4 for NHI director Tracy Colden reports only an acquisition of 1,268 restricted shares. It shows no sales or dispositions in this filing, with the transaction categorized as a grant or award that increased her direct holdings to 12,858 shares.